Ultra-fast deep-learned pediatric CNS tumor classification during surgery
Carlo VermeuleniD, Marc Pagès-GallegoiD, Lennart A. KesteriD, Mariëtte E.G. KranendonkiD, Pieter WesselingiD, Niels VerburgiD, Philip C. De Witt HameriD, Evert‐Jan KooiiD, Luuk Dankmeijer, Jasper van der LugtiD, Kirsten van Baarsen, Eelco Wieger HovingiD, Bastiaan B.J. TopsiD, Jeroen de RidderiD
Abstract
The primary treatment of CNS tumors starts with a neurosurgical resection in order to obtain tumor tissue for diagnosis and to reduce tumor load and mass effect. The neurosurgeon has to decide between radical resection versus a more conservative strategy to prevent surgical morbidity. The prognostic impact of a radical resection varies between tumor types. However due to a lack of pre-operative tissue-based diagnostics, limited knowledge of the precise tumor type is available at the time of surgery. Current standard practice includes preoperative imaging and intraoperative histological analysis, but these are not always conclusive. After surgery, histopathological and molecular tests are performed to diagnose the precise tumor type. The results may indicate that an additional surgery is needed or that the initial surgery could have been less radical. Using rapid Nanopore sequencing, a sparse methylation profile can be directly obtained during surgery, making it ideally suited to enable intraoperative diagnostics. We developed a state-of-the-art neural-network approach called Sturgeon, to deliver trained models that are lightweight and universally applicable across patients and sequencing depths. We demonstrate our method to be accurate and fast enough to provide a correct diagnosis with as little as 20 to 40 minutes of sequencing data in 45 out of 49 pediatric samples, and inconclusive results in the other four. In four intraoperative cases we achieved a turnaround time of 60-90 minutes from sample biopsy to result; well in time to impact surgical decision making. We conclude that machine-learned diagnosis based on intraoperative sequencing can assist neurosurgical decision making, allowing neurological comorbidity to be avoided or preventing additional surgeries.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 216
- FWCI
- 37.45
- Field percentile
- top 1%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Deep Learning Outperforms Classical Machine Learning Methods in Pediatric Brain Tumor Classification through Mass Spectra
Thais Maria Santos Bezerra, Matheus Silva de Deus, … João Meidânis·Intelligence-Based MedicinePeer-reviewed·Jan 1, 2024
- Diffusion Basis Spectrum Imaging with Deep Neural Network Differentiates Distinct Histology in Pediatric Brain Tumors
Zezhong Ye, Komal K. Srinivasa, … Joshua B. Rubin·bioRxiv·Apr 2, 2020
- iSCORED: nanopore-based random genomic sampling for intraoperative molecular diagnosis
Francesco E. Emiliani, Abdol Aziz Ould Ismail, … Chun‐Chieh Lin·medRxiv·Oct 17, 2023
- Towards accesible brain-tumor classification at the point of care Nanopore methylation sequencing from Formalin Fixed Paraffin Embedded (FFPE) pathology samples
Galina Feinberg‐Gorenshtein, Assaf Grunwald, … Yuval Ebenstein·medRxiv·May 2, 2024
- Single-cell RNA-sequencing of cerebral spinal fluid identifies circulating tumour cells in children with brain cancer
Chelsea Mayoh, Wenyan Li, … Robert Salomon·bioRxiv·Dec 22, 2025
- DIANA: An integrated pipeline for analysis of long-read whole-genome sequencing data for molecular neuropathology.
Christian Domilongo Bope, Henning Leske, … Skarphéðinn Halldórsson·bioRxiv·Mar 28, 2026